Prevalence and incidence of surgical site infections in the European Union/European Economic Area: how do these measures relate?


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 13 03 2019
accepted: 25 06 2019
pubmed: 3 7 2019
medline: 1 4 2020
entrez: 3 7 2019
Statut: ppublish

Résumé

In 2011-2012, the European Centre for Disease Prevention and Control (ECDC) initiated the first European point prevalence survey (PPS) of healthcare-associated infections (HCAIs) in addition to targeted surveillance of the incidence of specific types of HCAI such as surgical site infections (SSIs). To investigate whether national and multi-country SSI incidence can be estimated from ECDC PPS data. In all, 159 hospitals were included from 15 countries that participated in both ECDC surveillance modules, aligning surgical procedures in the incidence surveillance to corresponding specialties from the PPS. National daily prevalence of SSIs was simulated from the incidence surveillance data, the Rhame and Sudderth (R&S) formula was used to estimate national and multi-country SSI incidence from the PPS data, and national incidence per specialty was predicted using a linear model including data from the PPS. The simulation of daily SSI prevalence from incidence surveillance of SSIs showed that prevalence fluctuated randomly depending on the day of measurement. The correlation between the national aggregated incidence estimated with R&S formula and observed SSI incidence was low (correlation coefficient = 0.24), but specialty-specific incidence results were more reliable, especially when the number of included patients was large (correlation coefficients ranging from 0.40 to 1.00). The linear prediction model including PPS data had low proportion of explained variance (0.40). Due to a lack of accuracy, use of PPS data to estimate SSI incidence is recommended only in situations where incidence surveillance of SSIs is not performed, and where sufficiently large samples of PPS data are available.

Sections du résumé

BACKGROUND BACKGROUND
In 2011-2012, the European Centre for Disease Prevention and Control (ECDC) initiated the first European point prevalence survey (PPS) of healthcare-associated infections (HCAIs) in addition to targeted surveillance of the incidence of specific types of HCAI such as surgical site infections (SSIs).
AIM OBJECTIVE
To investigate whether national and multi-country SSI incidence can be estimated from ECDC PPS data.
METHODS METHODS
In all, 159 hospitals were included from 15 countries that participated in both ECDC surveillance modules, aligning surgical procedures in the incidence surveillance to corresponding specialties from the PPS. National daily prevalence of SSIs was simulated from the incidence surveillance data, the Rhame and Sudderth (R&S) formula was used to estimate national and multi-country SSI incidence from the PPS data, and national incidence per specialty was predicted using a linear model including data from the PPS.
FINDINGS RESULTS
The simulation of daily SSI prevalence from incidence surveillance of SSIs showed that prevalence fluctuated randomly depending on the day of measurement. The correlation between the national aggregated incidence estimated with R&S formula and observed SSI incidence was low (correlation coefficient = 0.24), but specialty-specific incidence results were more reliable, especially when the number of included patients was large (correlation coefficients ranging from 0.40 to 1.00). The linear prediction model including PPS data had low proportion of explained variance (0.40).
CONCLUSION CONCLUSIONS
Due to a lack of accuracy, use of PPS data to estimate SSI incidence is recommended only in situations where incidence surveillance of SSIs is not performed, and where sufficiently large samples of PPS data are available.

Identifiants

pubmed: 31265856
pii: S0195-6701(19)30276-2
doi: 10.1016/j.jhin.2019.06.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-411

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Auteurs

A P Meijs (AP)

Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. Electronic address: anouk.meijs@rivm.nl.

I Prantner (I)

National Center for Epidemiology, Department of Hospital Epidemiology and Hygiene, Budapest, Hungary; National Public Health Center, Budapest, Hungary.

T Kärki (T)

European Centre for Disease Prevention and Control, Solna, Sweden.

J A Ferreira (JA)

Department of Statistics, Informatics and Modelling, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

P Kinross (P)

European Centre for Disease Prevention and Control, Solna, Sweden.

E Presterl (E)

Medical University Vienna, Vienna, Austria.

P Märtin (P)

West Tallinn Central Hospital, Health Board, Tallinn, Estonia.

O Lyytikäinen (O)

National Institute for Health and Welfare, Helsinki, Finland.

S Hansen (S)

Institute of Hygiene and Environmental Health Charité, University Medicine Berlin, Berlin, Germany.

A Szőnyi (A)

National Center for Epidemiology, Department of Hospital Epidemiology and Hygiene, Budapest, Hungary; National Public Health Center, Budapest, Hungary.

E Ricchizzi (E)

Agenzia sanitaria e sociale regionale - Regione Emilia Romagna, Bologna, Italy.

R Valinteliėnė (R)

Institute of Hygiene, Vilnius, Lithuania.

S Zerafa (S)

Mater Dei Hospital, Msida, Malta.

S C de Greeff (SC)

Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

T C Berg (TC)

Norwegian Institute of Public Health, Oslo, Norway.

P A Fernandes (PA)

Direção-Geral da Saúde (DGS), Lisbon, Portugal.

M Štefkovičová (M)

Alexander Dubcek University in Trenčín and Regional Public Health Authority in Trenčín, Slovakia.

A Asensio (A)

Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.

T Lamagni (T)

Public Health England, London, England, UK.

M Sartaj (M)

HSC Public Health Agency, Belfast, Northern Ireland, UK.

J Reilly (J)

Health Protection Scotland National Services Scotland and Glasgow Caledonian University, Glasgow, Scotland, UK.

W Harrison (W)

Public Health Wales, Cardiff, Wales, UK.

C Suetens (C)

European Centre for Disease Prevention and Control, Solna, Sweden.

M B G Koek (MBG)

Centre for Infectious Diseases, Epidemiology and Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH